Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Shu-Jen Chen

1PUBLICATIONS

17CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 18, 2022

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

Pageof 1

Frequent Collaborators

1 joint publications

Nai-Jung Chiang

1 joint publications

Kien Thiam Tan

1 joint publications

Li-Yuan Bai

1 joint publications

Chin-Fu Hsiao

1 joint publications

Chung-Yu Huang

1 joint publications

Yi-Ping Hung

1 joint publications

Chien-Jui Huang

1 joint publications

San-Chi Chen

1 joint publications

Yan-Shen Shan

1 joint publications

Yee Chao

Frequent Collaborators

1 joint publications

Nai-Jung Chiang

1 joint publications

Kien Thiam Tan

1 joint publications

Li-Yuan Bai

1 joint publications

Chin-Fu Hsiao

Top Related Videos

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Published on : Apr 30, 2019

See more related videos

Top Related Videos

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Published on : Apr 30, 2019

See more related videos